Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib and baricitinib are similarly effective and safe for alopecia areata, but baricitinib works faster.

Sonidegib and vismodegib have different side effects and reporting patterns.

Longer treatment with vismodegib lowers relapse risk in basal cell carcinoma.

Baricitinib helps improve hair growth in severe alopecia, with better results in less severe cases and higher doses working faster.

Baricitinib effectively promotes long-term hair regrowth in alopecia areata patients.

JAK inhibitors like tofacitinib are effective and safer for severe alopecia areata than glucocorticosteroids.

Tofacitinib effectively reduced hair loss in alopecia areata patients without adverse effects.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

Provenge extends prostate cancer survival by about 4 months.

Gefitinib therapy can cause unusual hair growth on the nose.

EGFR-targeted cancer therapy can cause skin issues starting at hair follicles, leading to inflammation.

Oncology specialists are disappointed by the discontinuation of the effective lymphoma treatment Bexxar.

JAK inhibitors effectively treat severe alopecia areata with manageable side effects.

Targeting TCR-Vβ2 in cutaneous T cell lymphoma shows promise for safer, more specific treatment.

Previous alopecia areata treatments do not affect the long-term effectiveness of ritlecitinib.

Topical JAK inhibitors may help children with alopecia areata regrow hair.

Skin side effects from CDK4/6 inhibitors in breast cancer patients are generally mild and treatable, allowing most patients to continue treatment.

PI3Kδ inhibition may effectively treat cutaneous chronic graft-versus-host disease.

Tofacitinib effectively treated severe alopecia areata in a 14-year-old girl.

Long-term use of 5α-reductase inhibitors may improve survival in men with kidney cancer.

Sorafenib may cause hair loss in a way similar to alopecia areata.

Ritlecitinib effectively treats alopecia areata and is safe for long-term use in people 12 and older.

Vaccines and targeting TrxR variants can help prevent cancer and reduce metastasis.

Finasteride may help treat childhood brain tumors by activating certain genes.

Upadacitinib and oral minoxidil improved Crohn's disease and hair regrowth in a patient.

FOLFOX6 chemotherapy effectively reduces VEGF levels and improves quality of life in advanced colorectal cancer patients.

PF-05314882 selectively activates androgen receptors without much effect on prostate and may help in prostate cancer treatment and hair loss prevention.